Detalhe da pesquisa
1.
Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL).
Lancet
; 401(10370): 25-37, 2023 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36493791
2.
Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-α inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE).
Lancet
; 401(10370): 38-48, 2023 01 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36495881
3.
IL-23 induces CLEC5A+ IL-17A+ neutrophils and elicit skin inflammation associated with psoriatic arthritis.
J Autoimmun
; 143: 103167, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38301504
4.
Vaccination recommendations for adults receiving biologics and oral therapies for psoriasis and psoriatic arthritis: Delphi consensus from the medical board of the National Psoriasis Foundation.
J Am Acad Dermatol
; 2024 Feb 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38331098
5.
Bimekizumab treatment in biologic DMARD-naïve patients with active psoriatic arthritis: 52-week efficacy and safety results from the phase III, randomised, placebo-controlled, active reference BE OPTIMAL study.
Ann Rheum Dis
; 82(11): 1404-1414, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37696588
6.
Guselkumab provides sustained domain-specific and comprehensive efficacy using composite indices in patients with active psoriatic arthritis.
Rheumatology (Oxford)
; 62(2): 606-616, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35766811
7.
Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNFα inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial.
Lancet
; 395(10230): 1115-1125, 2020 04 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32178765
8.
Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial.
Lancet
; 395(10222): 427-440, 2020 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32035552
9.
Resolution of enthesitis by guselkumab and relationships to disease burden: 1-year results of two phase 3 psoriatic arthritis studies.
Rheumatology (Oxford)
; 60(11): 5337-5350, 2021 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33822898
10.
National Psoriasis Foundation COVID-19 Task Force guidance for management of psoriatic disease during the pandemic: Version 2-Advances in psoriatic disease management, COVID-19 vaccines, and COVID-19 treatments.
J Am Acad Dermatol
; 84(5): 1254-1268, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33422626
11.
TNF-Induced Interstitial Lung Disease in a Murine Arthritis Model: Accumulation of Activated Monocytes, Conventional Dendritic Cells, and CD21+/CD23- B Cell Follicles Is Prevented with Anti-TNF Therapy.
J Immunol
; 203(11): 2837-2849, 2019 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31659014
12.
Overview of the Grant Writing Workshop From the GRAPPA 2020 Annual Meeting.
J Rheumatol Suppl
; 97: 17-18, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34074660
13.
GRAPPA Trainee Symposium 2020: A Summary of Oral and Poster Presentations.
J Rheumatol Suppl
; 97: 19-23, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34074661
14.
Proceedings of the 2020 GRAPPA Collaborative Research Network (CRN) Meeting.
J Rheumatol Suppl
; 97: 4-9, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-34074658
15.
National Psoriasis Foundation COVID-19 Task Force Guidance for Management of Psoriatic Disease During the Pandemic: Version 1.
J Am Acad Dermatol
; 83(6): 1704-1716, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32891785
16.
Moving Toward Precision Medicine in Psoriasis and Psoriatic Arthritis.
J Rheumatol Suppl
; 96: 19-24, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32482763
17.
GRAPPA Trainees Symposium 2019: A Report from the GRAPPA 2019 Annual Meeting.
J Rheumatol Suppl
; 96: 4-10, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32482761
18.
Proceedings of the 2019 GRAPPA Collaborative Research Network Meeting.
J Rheumatol Suppl
; 96: 25-30, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32482764
19.
GRAPPA 2019 Project Report.
J Rheumatol Suppl
; 96: 53-57, 2020 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-32482770
20.
Inhibition of radiographic progression in psoriatic arthritis by adalimumab independent of the control of clinical disease activity.
Rheumatology (Oxford)
; 58(6): 1025-1033, 2019 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30608620